These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30509851)

  • 1. How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria.
    Amadi C; Tsui EK
    Res Social Adm Pharm; 2019 Nov; 15(11):1344-1357. PubMed ID: 30509851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of national tax policy on local pharmaceutical production in a southwestern state nigeria - qualitative research for the intersection of national pharmaceutical policy on health systems development.
    Obembe TA; Adenipekun AB; Morakinyo OM; Odebunmi KO
    BMC Health Serv Res; 2022 Feb; 22(1):264. PubMed ID: 35220971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supply chain management of health commodities for reducing global disease burden.
    Chukwu OA; Ezeanochikwa VN; Eya BE
    Res Social Adm Pharm; 2017; 13(4):871-874. PubMed ID: 27720436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholder perspectives on the challenges surrounding management and supply of essential medicines.
    Duong MH; Moles RJ; Chaar B; Chen TF
    Int J Clin Pharm; 2019 Oct; 41(5):1210-1219. PubMed ID: 31444686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.
    Flood D; Mathieu I; Chary A; García P; Rohloff P
    BMC Health Serv Res; 2017 Jan; 17(1):27. PubMed ID: 28086866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies.
    Al-Jumaili AA; Younus MM; Saleh MZ
    Pharmaceut Med; 2021 May; 35(3):169-186. PubMed ID: 33864206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pharmacists in eliminating counterfeit medicines in Nigeria.
    Adigwe OP
    Front Public Health; 2023; 11():1170929. PubMed ID: 37674683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflated medicine prices in Vietnam: a qualitative study.
    Nguyen TA; Knight R; Mant A; Razee H; Brooks G; Dang TH; Roughead EE
    Health Policy Plan; 2017 Jun; 32(5):647-656. PubMed ID: 28453716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of government in the achievement of medicines' security: A preliminary exploration of stakeholders' views and experience.
    Adigwe OP; Onavbavba G
    PLoS One; 2024; 19(6):e0299978. PubMed ID: 38848401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
    Orubu ESF; Robert FO; Samuel M; Megbule D
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Essential Medicines from Different Sources in Enugu and Anambra, Nigeria.
    Gabel J; Lächele M; Sander K; Gnegel G; Sunny-Abarikwu N; Ohazulike RE; Ngene J; Chioke JF; Häfele-Abah C; Heide L
    Am J Trop Med Hyg; 2024 Jul; 111(1):179-195. PubMed ID: 38740019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are essential medicines in Malaysia accessible, affordable and available?
    Saleh K; Ibrahim MI
    Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
    Lipworth W; Doran E; Kerridge I; Day R
    Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An absence of evidence breeds contempt: A qualitative study of health system stakeholder perceptions of the quality of medicines available in Senegal.
    Lalani M; Matafwali SK; Ndiaye AD; Webster J; Clarke SE; Kaur H
    PLOS Glob Public Health; 2023; 3(7):e0002004. PubMed ID: 37437003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
    Coghlan R; Stephens P; Mwale B; Siyanga M
    Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers.
    Garuba HA; Kohler JC; Huisman AM
    Global Health; 2009 Oct; 5():14. PubMed ID: 19874613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.